Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (≥ 80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database
Authors:
- Nicholas CorsiNCNicholas Corsi
- David-Dan NguyenDNDavid-Dan Nguyen
- Adel ArezkiAAAdel Arezki
- Iman SadriISIman Sadri
- Kyle LawKLKyle Law
- David BouhadanaDBDavid Bouhadana
- Claudia DeyirmendjianCDClaudia Deyirmendjian
- Naeem BhojaniNBNaeem Bhojani
- Dean S. EltermanDEDean S. Elterman
- Franck BruyèreFBFranck Bruyère
- Luca CindoloLCLuca Cindolo
- Giovanni FerrariGFGiovanni Ferrari
- 19 December 2022
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 41 (2) , 529-536
Abstract
Introduction GreenLight photoselective vaporization of the prostate (PVP) has gained widespread adoption as an option to traditional transurethral resection of the prostate. Prior reports expressed concern with the use of PVP in large prostates. The aim of this study was to investigate the adjusted outcomes of GreenLight PVP in men with large (≥ 80 cc) vs. small prostates (< 80 cc). Methods Data were obtained from the Global Greenlight Group which pools data from 7 high volume centers. Men with established benign prostatic hyperplasia who underwent GreenLight PVP using the XPS-180 W system between 2011 and 2019 were eligible and assigned into two groups based on their prostate size (≥ 80 and < 80 cc). 11 functional and perioperative covariates were collected. Analyses were adjusted for patient age and presence of median lobe. Results 3426 men met the inclusion criteria. 34.6% (n = 1187) of patients had a large prostate size. Baseline age and prostate volume were significantly different between the groups. The magnitude of absolute improvement in unadjusted international prostate symptom score was significantly greater in the large (≥ 80 cc) prostate group at 12 months, with an absolute change of 19.17 points (95% CI 18.46–19.88; p < 0.01). There was also a significant drop in PVR at both 6- (p = 0.007) and 12 months (p = 0.005). There were no significant differences in transfusion (p = 0.42), hematuria (p = 0.80), or 30-day readmission rates (p = 0.28). Conclusions Greenlight PVP is a safe and effective alternative for patients with prostate sizes ≥ 80 cc, with durable outcomes relatively independent from prostate size.Keywords
This publication has 26 references indexed in Scilit:
- Résultats de la photovaporisation prostatique par laser GreenLight XPS-180 W dans l’hyperplasie bénigne de prostate (HBP) de gros volume (≥ 80 mL)Progrès en Urologie, 2017
- Multicenter international experience of 532 nm-laser photo-vaporization with Greenlight XPS in men with large prostates (prostate volume > 100 cc)World Journal of Urology, 2017
- Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo‐Joules per gram of prostate?BJU International, 2016
- GreenLight laser for prostates over 100 mlCurrent Opinion in Urology, 2016
- EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic ObstructionEuropean Urology, 2015
- Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and OutcomesJournal of Urology, 2015
- Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)Frontiers in Genetics, 2015
- 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mLLasers in Medical Science, 2014
- 180-W XPS GreenLight Laser Vaporisation Versus Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 6-Month Safety and Efficacy Results of a European Multicentre Randomised Trial—The GOLIATH StudyEuropean Urology, 2014
- Accuracy and repeatability of prostate volume measurements by transrectal ultrasoundProstate Cancer and Prostatic Diseases, 2002